Table 6 Number of post-operative events and costs avoided (national-level results)
Block Depth At Reversal | Prior NMBA & Reversal Agent | Number of Post-operative events (Prior Scenario) | Number of Post-operative events (Alternative Scenario) | Costs of post-operative events (Prior scenario) | Costs of post-operative events (Alternative scenario) |
|---|---|---|---|---|---|
Moderate | Rocuronium + No reversal | 13,296 | 3599 | €54,335,758 | €18,027,560 |
Moderate | Rocuronium + Neostigmine | 9161 | 2480 | €37,435,478 | €12,420,372 |
Deep | Rocuronium + No reversal | 3324 | 900 | €13,583,939 | €4,506,890 |
Total | 25,781 | 6979 | €105,355,176 | €34,954,822 | |
4806 pneumonia cases avoided 13,996 atelectasis cases avoided | €70,400,354 costs avoided with sugammadex use | ||||